Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p/19q-codeletion status in diffuse gliomas without intense contrast enhancement Reviewed International journal

Koji Yamashita 1, Osamu Togao 2, Kazufumi Kikuchi 3, Daisuke Kuga 4, Yuhei Sangatsuda 4, Yutaka Fujioka 4, Izumi Kinoshita 5, Makoto Obara 6, Koji Yoshimoto 4, Kousei Ishigami 3

Neuroradiology   2023.9

Impact of Positive-Margin Resection of External Auditory Canal Squamous Cell Carcinoma Reviewed International journal

Noritaka Komune 1, Ryosuke Kuga 1 2, Takahiro Hongo 1, Daisuke Kuga 3, Kuniaki Sato 1, Takashi Nakagawa 1

Cancers   2023.8

Supramaximal Resection Can Prolong the Survival of Patients with Cortical Glioblastoma: A Volumetric Study Reviewed International journal

Ryosuke Otsuji 1, Nobuhiro Hata 1 2, Yusuke Funakoshi 1, Daisuke Kuga 1, Osamu Togao 3, Ryusuke Hatae 1, Yuhei Sangatsuda 1, Yutaka Fujioka 1, Kosuke Takigawa 1, Aki Sako 1, Kazufumi Kikuchi 3, Tadamasa Yoshitake 3, Hidetaka Yamamoto 4, Masahiro Mizoguchi 1, Koji Yoshimoto 1

Neurologia medigco-chirurgica   2023.7

Predicting TERT promoter mutation status using 1H-MR spectroscopy and stretched-exponential model of diffusion-weighted imaging in IDH-wildtype diffuse astrocytic glioma without intense enhancement Reviewed International journal

Koji Yamashita 1, Ryusuke Hatae 2, Kazufumi Kikuchi 3, Daisuke Kuga 2, Nobuhiro Hata 2, Hidetaka Yamamoto 4, Makoto Obara 5, Koji Yoshimoto 2, Kousei Ishigami 3, Osamu Togao 6

Neuroradiology   2023.7

Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma Reviewed International journal

Nayuta Higa 1 2, Toshiaki Akahane 3 4, Seiya Yokoyama 3, Ryutaro Makino 1, Hajime Yonezawa 1, Hiroyuki Uchida 1, Tomoko Takajo 1, Mari Kirishima 3, Taiji Hamada 3, Naoki Noguchi 2, Ryosuke Otsuji 2, Daisuke Kuga 2, Shohei Nagasaka 5, Hitoshi Yamahata 1, Junkoh Yamamoto 5, Koji Yoshimoto 2, Akihide Tanimoto 3 4, Ryosuke Hanaya

Neuro-Oncology ADVANCES   2023.6

Induction of glioblastoma cell ferroptosis using combined treatment with chloramphenicol and 2-deoxy-D-glucose Reviewed International journal

Kenji Miki 1 2, Mikako Yagi 1 3, Naoki Noguchi 2, Yura Do 1, Ryosuke Otsuji 2, Daisuke Kuga 2, Dongchon Kang 1, Koji Yoshimoto 2, Takeshi Uchiumi

Scientific Reports   2023.6

Liquid biopsy with multiplex ligation-dependent probe amplification targeting cell-free tumor DNA in cerebrospinal fluid from patients with adult diffuse glioma. Reviewed International journal

Otsuji R, Fujioka Y, Hata N, Kuga D, Sangatsuda Y, Takigawa K, Funakoshi Y, Sako A, Yamamoto H, Nakamizo A, Mizoguchi M, Yoshimoto K.

Neuro-Oncology ADVANCES   2022.11

Quantitative relaxometry using synthetic MRI could be better than T2-FLAIR mismatch sign for differentiation of IDH-mutant gliomas: a pilot study. Reviewed International journal

Kikuchi K, Togao O, Yamashita K, Momosaka D, Kikuchi Y, Kuga D, Hata N, Mizoguchi M, Yamamoto H, Iwaki T, Hiwatashi A, Ishigami K.

Science Reports   2022.6

Clinical Analysis of En Bloc Resection for Advanced Temporal Bone Squamous Cell Carcinoma Reviewed International journal

Skull base   2022.6

Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomas. Reviewed International journal

Takase H, Togao O, Kikuchi K, Hata N, Hatae R, Chikui T, Tokumori K, Kami Y, Kuga D, Sangatsuda Y, Mizoguchi M, Hiwatashi A, Ishigami K.

British Journal of Radiology   2022.5

Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective Study Reviewed International journal

YusukeFunakoshi1KosukeTakigawa1NobuhiroHata1DaisukeKuga1RyusukeHatae1YuheiSangatsuda1YutakaFujioka1RyosukeOtsuji1AkiSako1TadamasaYoshitake2OsamuTogao2AkioHiwatashi2ToruIwaki3MasahiroMizoguchi1KojiYoshimoto1

World Neurosugery   2022.3

Clinical implications of molecular analysis in diffuse glioma stratification Reviewed International journal

Masahiro Mizoguchi, Nobuhiro Hata, Daisuke Kuga, Ryusuke Hatae, Yojiro Akagi, Yuhei Sangatsuda, Yutaka Fujioka, Kosuke Takigawa, Yusuke Funakoshi, Satoshi O. Suzuki & Toru Iwaki

Brain tumor pathology   2021.7

Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversy Reviewed International journal

Masayuki Kanamori 1, Hirokazu Takami 2 3, Tomonari Suzuki 4, Teiji Tominaga 1, Jun Kurihara 5, Shota Tanaka 2, Seiji Hatazaki 6, Motoo Nagane 7, Masahide Matsuda 8, Atsuo Yoshino 9, Manabu Natsumeda 10, Masayoshi Yamaoka 11, Naoki Kagawa 12, Yukinori Akiyama 13, Junya Fukai 14, Tetsuya Negoto 15, Ichiyo Shibahara 16, Kazuhiro Tanaka 17, Akihiro Inoue 18, Mitsuhiro Mase 19, Takahiro Tomita 20, Daisuke Kuga 21, Noriyuki Kijima 22, Tadateru Fukami 23, Yukiko Nakahara 24, Atsushi Natsume 25, Koji Yoshimoto 26, Dai Keino 27, Tsutomu Tokuyama 28, Kenichiro Asano 29, Kenta Ujifuku 30, Hiroshi Abe 31, Mitsutoshi Nakada 32, Ken-Ichiro Matsuda 33, Yoshiki Arakawa 34, Naokado Ikeda 35, Yoshitaka Narita 36, Naoki Shinojima 37, Atsushi Kambe 38, Masahiko Nonaka 39, Shuichi Izumoto 40, Yu Kawanishi 41, Kohei Kanaya 42, Sadahiro Nomura 43, Kohei Nakajima 44, Shohei Yamamoto 45, Keita Terashima 46, Koichi Ichimura 3, Ryo Nishikawa

Neuro-Oncology ADVANCES   2021.6

Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing c Reviewed International journal

Kosuke Takigawa, Nobuhiro Hata, Yuhei Michiwaki, Akio Hiwatashi, Hajime Yonezawa, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Yusuke Funakoshi, Ryosuke Otsuji, Aki Sako, Osamu Togao, Takashi Yoshiura, Koji Yoshimoto & Masahiro Mizoguchi

Journal of Neuro-oncology   2021.5

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma. Invited Reviewed International journal

2021.5

Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid. Invited Reviewed International journal

Yutaka Fujioka, Nobuhiro Hata, Yojiro Akagi, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yuhei Michiwaki, Takeo Amemiya, Kosuke Takigawa, Yusuke Funakoshi, Aki Sako, Toru Iwaki, Koji Iihara & Masahiro Mizoguchi

Journal of Neuro-oncology   2021.5

A Pedicled Posterior Septal–Nasal Floor Flap and a Novel Rescue Flap for Skull Base Reconstruction Reviewed International journal

2021.3

Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid Reviewed International journal

Fujioka Y, Hata N, Akagi Y, Kuga D, Hatae R, Sangatsuda Y, Michiwaki Y, Amemiya T, Takigawa K, Funakoshi Y, Sako A, Iwaki T, Iihara K, Mizoguchi M.

Journal of Neurooncology   2021.3

A Pedicled Posterior Septal-Nasal Floor Flap and a Novel Rescue Flap for Skull Base Reconstruction. Invited Reviewed International journal

Murakami D, Kuga D, Miyamoto Y, Komune N, Mukae N, Saito Y, Iihara K, Nakagawa T.

World Neurosurgery   2021.3

So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma? Reviewed International journal

Kanamori M, Takami H, Yamaguchi S, Sasayama T, Yoshimoto K, Tominaga T, Inoue A, Ikeda N, Kambe A, Kumabe T, Matsuda M, Tanaka S, Natsumeda M, Matsuda KI, Nonaka M, Kurihara J, Yamaoka M, Kagawa N, Shinojima N, Negoto T, Nakahara Y, Arakawa Y, Hatazaki S, Shimizu H, Yoshino A, Abe H, Akimoto J, Kawanishi Y, Suzuki T, Natsume A, Nagane M, Akiyama Y, Keino D, Fukami T, Tomita T, Kanaya K, Tokuyama T, Izumoto S, Nakada M, Kuga D, Yamamoto S, Anei R, Uzuka T, Fukai J, Kijima N, Terashima K, Ichimura K, Nishikawa R.

Neuro-oncology   2021.2

Mesenchymal glioblastoma-induced mature de-novo vessel formation of vascular endothelial cells in a microfluidic device. Reviewed International journal

Amemiya T, Hata N, Mizoguchi M, Yokokawa R, Kawamura Y, Hatae R, Sangatsuda Y, Kuga D, Fujioka Y, Takigawa K, Akagi Y, Yoshimoto K, Iihara K, Miura T.

Mol Biol Rep   2021.1

Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas Reviewed International journal

Togao O, Chikui T, Tokumori K, Kami Y, Kikuchi K, Momosaka D, Kikuchi Y, Kuga D, Hata N, Mizoguchi M, Iihara K, Hiwatashi A.

Plos One   2020.12

Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma. Reviewed International journal

Funakoshi Y, Hata N, Kuga D, Hatae R, Sangatsuda Y, Fujioka Y, Takigawa K, Mizoguchi M.

Pharmaceuticals   2020.12

Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors Reviewed International journal

Sangatsuda Y, Miura F, Araki H, Mizoguchi M, Hata N, Kuga D, Hatae R, Akagi Y, Amemiya T, Fujioka Y, Arai Y, Yoshida A, Shibata T, Yoshimoto K, Iihara K, Ito T.

Scientific reports   2020.9

Differentiation of high-grade from low-grade diffuse gliomas using diffusion-weighted imaging a comparative study of mono-, bi-, and stretched-exponential diffusion models Reviewed International journal

Masaoki Kusunoki, Kazufumi Kikuchi, Osamu Togao, Koji Yamashita, Daichi Momosaka, Yoshitomo Kikuchi, Daisuke Kuga, Nobuhiro Hata, Masahiro Mizoguchi, Koji Iihara, Satoshi O. Suzuki, Toru Iwaki, Yuta Akamine, Akio Hiwatashi

Neuroradiology   62 ( 7 )   815 - 823   2020.7

Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification Invited Reviewed International journal

Yuhei Michiwaki, Nobuhiro Hata, Masahiro Mizoguchi, Akio Hiwatashi, Daisuke Kuga, Ryusuke Hatae, Yojiro Akagi, Takeo Amemiya, Yutaka Fujioka, Osamu Togao, Satoshi O. Suzuki, Koji Yoshimoto, Toru Iwaki, Koji Iihara

Clinical Neurology and Neurosurgery   187   2019.12

Correlation between prognosis of glioblastoma and choline/N-acetyl aspartate ratio in MR spectroscopy Invited Reviewed International journal

Yojiro Akagi, Naoki Noguchi, Nobuhiro Hata, Ryusuke Hatae, Yuhei Michiwaki, Yuhei Sangatsuda, Takeo Amemiya, Daisuke Kuga, Koji Yamashita, Osamu Togao, Akio Hiwatashi, Koji Yoshimoto, Masahiro Mizoguchi, Koji Iihara

Interdisciplinary Neurosurgery: Advanced Techniques and Case Management   18   2019.12

Predictors of recurrence and postoperative outcomes in patients with non-skull base meningiomas based on modern neurosurgical standards Reviewed International journal

Yuhei Michiwaki, Nobuhiro Hata, Toshiyuki Amano, Satoshi O. Suzuki, Yojiro Akagi, Daisuke Kuga, Daisuke Onozuka, Seiya Momosaki, Akira Nakamizo, Koji Yoshimoto, Toru Iwaki, Koji Iihara

Interdisciplinary Neurosurgery: Advanced Techniques and Case Management   15   30 - 37   2019.3

Predicting TERT promoter mutation using MR images in patients with wild-type IDH1 glioblastoma Reviewed

K. Yamashita, R. Hatae, Hiwatashi Akio, Osamu Togao, kazufumi kikuchi, D. Momosaka, Y. Yamashita, Daisuke Kuga, Nobuhiro Hata, K. Yoshimoto, S. O. Suzuki, Toru Iwaki, Koji Iihara, Hiroshi Honda

Diagnostic and Interventional Imaging   2019.1

Endoscopic Endonasal Approach Combined with a Simultaneous Transcranial Approach for Giant Pituitary Tumors Reviewed International journal

Daisuke Kuga, Masahiro Toda, Hiroyuki Ozawa, Kaoru Ogawa, Kazunari Yoshida

World Neurosurgery   121   173 - 179   2019.1

Treatment Strategy for Tuberculum Sellae Meningiomas Based on a Preoperative Radiological Assessment Reviewed International journal

Daisuke Kuga, Masahiro Toda, Kazunari Yoshida

World Neurosurgery   120   e1279 - e1288   2018.12

The Effectiveness of Salvage Treatments for Recurrent Lesions of Oligodendrogliomas Previously Treated with Upfront Chemotherapy Reviewed International journal

Daisuke Kuga, Nobuhiro Hata, Yojiro Akagi, Takeo Amemiya, yuhei sangatsuda, Ryusuke Hatae, Koji Yoshimoto, Masahiro Mizoguchi, Koji Iihara

World Neurosurgery   114   e735 - e742   2018.6

Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification Reviewed International journal

Yojiro Akagi, Koji Yoshimoto, Nobuhiro Hata, Daisuke Kuga, Ryusuke Hatae, Takeo Amemiya, yuhei sangatsuda, Satoshi Suzuki, Toru Iwaki, Masahiro Mizoguchi, Koji Iihara

Brain tumor pathology   1 - 9   2018.3

High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas Reviewed International journal

Koji Yoshimoto, Ryusuke Hatae, Satoshi Suzuki, Nobuhiro Hata, Daisuke Kuga, Yojiro Akagi, Takeo Amemiya, yuhei sangatsuda, Nobutaka Mukae, Masahiro Mizoguchi, Toru Iwaki, Koji Iihara

Neuropathology   38 ( 1 )   3 - 10   2018.2

Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas a retrospective study of 411 consecutive glioma cases in a single institution Reviewed

Koji Yoshimoto, Ryusuke Hatae, Yuhei Sangatsuda, Satoshi Suzuki, Nobuhiro Hata, Yojiro Akagi, Daisuke Kuga, Murata Hideki, Koji Yamashita, Osamu Togao, Hiwatashi Akio, Toru Iwaki, Masahiro Mizoguchi, Koji Iihara

Brain Tumor Pathology   34 ( 3 )   103 - 112   2017.7

Insular primary glioblastomas with IDH mutations Clinical and biological specificities Reviewed

Nobuhiro Hata, Ryusuke Hatae, Koji Yoshimoto, Hideki Murata, Daisuke Kuga, Yojiro Akagi, Yuhei Sangatsuda, Satoshi Suzuki, Toru Iwaki, Masahiro Mizoguchi, Koji Iihara

Neuropathology   37 ( 3 )   200 - 206   2017.6

A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology Reviewed

Ryusuke Hatae, Nobuhiro Hata, Satoshi Suzuki, Koji Yoshimoto, Daisuke Kuga, Hideki Murata, Yojiro Akagi, Yuhei Sangatsuda, Toru Iwaki, Masahiro Mizoguchi, Koji Iihara

Neuropathology   37 ( 3 )   191 - 199   2017.6

Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution Invited Reviewed International journal

Brain Tumor pathology   2017.6

Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging comparisons with diffusion- and perfusion-weighted imaging Reviewed

Osamu Togao, Hiwatashi Akio, Koji Yamashita, kazufumi kikuchi, Jochen Keupp, Koji Yoshimoto, Daisuke Kuga, Masami Yoneyama, Satoshi Suzuki, Toru Iwaki, Masaya Takahashi, Koji Iihara, Hiroshi Honda

European Radiology   27 ( 2 )   578 - 588   2017.2

Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status Reviewed

Nobuhiro Hata, Koji Yoshimoto, Ryusuke Hatae, Daisuke Kuga, Yojiro Akagi, Yuhei Sangatsuda, Satoshi Suzuki, Tadahisa Shono, Masahiro Mizoguchi, Koji Iihara

OncoTargets and Therapy   10   429 - 437   2017.1

A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology. Invited Reviewed International journal

Neuropathology   2017.1

Insular primary glioblastomas with IDH mutations: Clinical and biological specificities. Invited Reviewed International journal

2017.1

Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status. Invited Reviewed International journal

Onco Targets and therapy   2017.1

A case of concurrent schwannoma and meningioma at the same cervical level Reviewed

Satoshi Karashima, Koichi Arimura, Kimiaki Hashiguchi, Yojiro Akagi, Nobutaka Mukae, ataru nishimura, Daisuke Kuga, Koji Yoshimoto, Tetsuro Sayama, Satoshi Suzuki, Koji Iihara

Japanese Journal of Neurosurgery   26 ( 10 )   750 - 756   2017

Indications and limitations of endoscopic endonasal surgery Reviewed

Koji Yoshimoto, Nobutaka Mukae, Daisuke Kuga, Koji Iihara

Japanese Journal of Neurosurgery   26 ( 6 )   404 - 411   2017

Dual optical channel three-dimensional neuroendoscopy Clinical application as an assistive technique in endoscopic endonasal surgery Reviewed

Koji Yoshimoto, Nobutaka Mukae, Daisuke Kuga, Daisuke Inoue, Makoto Hashizume, Koji Iihara

Interdisciplinary Neurosurgery: Advanced Techniques and Case Management   6   45 - 50   2016.12

Deferred radiotherapy and upfront procarbazine-ACNU-vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade. Invited Reviewed International journal

2016.11

Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme Reviewed

Koji Yamashita, Hiwatashi Akio, Osamu Togao, kazufumi kikuchi, Yoshiyuki Kitamura, Masahiro Mizoguchi, Koji Yoshimoto, Daisuke Kuga, Satoshi Suzuki, Shingo Baba, Takuro Isoda, Toru Iwaki, Koji Iihara, Hiroshi Honda

Journal of Magnetic Resonance Imaging   44 ( 5 )   1256 - 1261   2016.11

Deferred radiotherapy and upfront procarbazine-ACNU-vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade Reviewed

Nobuhiro Hata, Koji Yoshimoto, Ryusuke Hatae, Daisuke Kuga, Yojiro Akagi, Satoshi Suzuki, Toru Iwaki, Tadahisa Shono, Masahiro Mizoguchi, Koji Iihara

OncoTargets and Therapy   9   7123 - 7131   2016.11

Current Trends and Healthcare Resource Usage in the Hospital Treatment of Primary Malignant Brain Tumor in Japan: A National Survey Using the Diagnostic Procedure Combination Database (J-ASPECT Study-Brain Tumor). Invited Reviewed International journal

Neurol Med Chir   2016.11

Precise Detection of IDH1/2 and BRAF Hotspot Mutations in Clinical Glioma Tissues by a Differential Calculus Analysis of High-Resolution Melting Data. Invited Reviewed International journal

Plos one   2016.8

Precise detection of IDH1/2 and BRAF hotspot mutations in clinical glioma tissues by a differential calculus analysis of high-resolution melting data Reviewed

Ryusuke Hatae, Nobuhiro Hata, Koji Yoshimoto, Daisuke Kuga, Yojiro Akagi, Hideki Murata, Satoshi O. Suzuki, Masahiro Mizoguchi, Koji Iihara

PloS one   11 ( 8 )   2016.8

Current trends and healthcare resource usage in the hospital treatment of primary malignant brain tumor in Japan A national survey using the diagnostic procedure combination database (J-ASPECT study-brain tumor) Reviewed

Koji Yoshimoto, Akiko Kada, Daisuke Kuga, Ryusuke Hatae, Hideki Murata, Yojiro Akagi, Kunihiro Nishimura, Ryota Kurogi, Ataru Nishimura, Nobuhiro Hata, Masahiro Mizoguchi, Tetsuro Sayama, Koji Iihara

Neurologia medico-chirurgica   56 ( 11 )   664 - 673   2016

Detection of proneural/mesenchymal marker expression in glioblastoma temporospatial dynamics and association with chromatin-modifying gene expression Reviewed

Hideki Murata, Koji Yoshimoto, Ryusuke Hatae, Yojiro Akagi, Masahiro Mizoguchi, Nobuhiro Hata, Daisuke Kuga, Akira Nakamizo, Toshiyuki Amano, Tetsuro Sayama, Koji Iihara

Journal of Neuro-Oncology   125 ( 1 )   33 - 41   2015.10

Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma Reviewed

Xinlong Ma, Koji Yoshimoto, Yaulei Guan, Nobuhiro Hata, Masahiro Mizoguchi, Noriaki Sagata, Hideki Murata, Daisuke Kuga, Toshiyuki Amano, Akira Nakamizo, Tomio Sasaki

Neuro-Oncology   14 ( 9 )   1153 - 1162   2012.9

Expression of stem cell marker and receptor kinase genes in glioblastoma tissue quantified by real-time RT-PCR Reviewed

Koji Yoshimoto, Xinlong Ma, Yaulei Guan, Masahiro Mizoguchi, Akira Nakamizo, Toshiyuki Amano, Nobuhiro Hata, Daisuke Kuga, Tomio Sasaki

Brain tumor pathology   28 ( 4 )   291 - 296   2011.10

Erratum Loss of heterozygosity analysis in malignant gliomas (Brain Tumor Pathol DOI: 10.1007/s10014-011-0038-0) Reviewed

Masahiro Mizoguchi, Daisuke Kuga, Yanlei Guan, Nobuhiro Hata, Akira Nakamizo, Koji Yoshimoto, Tomio Sasaki

Brain tumor pathology   28 ( 3 )   197   2011.7

Loss of heterozygosity analysis in malignant gliomas Reviewed

Masahiro Mizoguchi, Daisuke Kuga, Yanlei Guan, Nobuhiro Hata, Akira Nakamizo, Koji Yoshimoto, Tomio Sasaki

Brain tumor pathology   28 ( 3 )   191 - 196   2011.7

MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance Reviewed

Yanlei Guan, Masahiro Mizoguchi, Koji Yoshimoto, Nobuhiro Hata, Tadahisa Shono, Satoshi O. Suzuki, Yukie Araki, Daisuke Kuga, Akira Nakamizo, Toshiyuki Amano, Xinlong Ma, Kenshi Hayashi, Tomio Sasaki

Clinical Cancer Research   16 ( 16 )   4289 - 4297   2010.8

耳鼻科合同での経鼻内視鏡下頭蓋底手術の導入とその有用性 International conference

空閑　太亮、村上　大輔、迎　伸孝、小宗　徳孝、宮本　雄介、秦　暢宏、溝口　昌弘、中川　尚志、飯原　弘二

第24回脳腫瘍の外科学会  2019.9 

Optimal Management of Functional Outcomes in Patients with Central Nervous System Germ Cell Tumors: Recommendations Based on 25 Years of Experience at a Single Institution International conference

Daisuke Kuga MD, PhD1; Toshiyuki Amano MD, PhD2; Yojiro Akagi MD1; Takeo Amemiya MD1; Yuhei Sangatsuda MD1; Ryusuke Hatae MD, PhD1; Nobuhiro Hata MD, PhD1; Koji Yoshimoto MD, PhD1; Masahiro Mizotuchi MD, PhD3; Koji Iihara MD, PhD1

Asian Society of Neuro-oncology  2019.9 

免疫染色によるグリオーマ層別化の検討

空閑太亮　溝口昌弘　鈴木諭　藤岡寛　雨宮健生　三月田祐平　赤木洋二郎　　波多江龍亮　秦暢宏　岩城徹　飯原弘二

日本脳腫瘍学会  2018.12 

腫瘍発生母地と進展方向を考慮した鞍結節部／蝶形骨平面髄膜腫手術アプローチの選択

空閑　太亮

日本頭蓋底外科学会  2018.8 

Clinical significance of salvage surgery for recurrent IDH-mutant and 1p/19q-codeleted oligodendroglial tumor. International conference

Daisuke Kuga

ASNO  2017.11 

IDH mutant, 1p/19q codeletd Oligodendroglial tumorの長期予後

空閑 太亮

日本脳神経外科学会総会  2016.10 

当院における小児頭蓋内胚細胞腫瘍の長期治療成績と機能予後

空閑 太亮

小児脳神経外科学会  2016.6 

ATRX免疫染色によるグリオーマ層別化の検討

空閑 太亮

日本脳腫瘍病理学会  2016.5 

頭蓋底腫瘍に対するEndoscopic transoral approach Robotic surgeryを見据えて

空閑 太亮1, 村上 大輔2, 小宗 徳孝2, 藤岡 寛1, 三月田 祐平1, 下川 能史1, 宮本 雄介2, 中溝 玲1, 吉本 幸司1

第82回日本日本脳神経外科学会学術総会.  2023.10 

PitNET患者に対する外科手術の視機能関連QOLへの影響

空閑 太亮, 三月田 祐平, 藤岡 寛, 中溝 玲, 吉本 幸司

第２９回脳腫瘍の外科学会  2023.9 

経鼻内視鏡手術時代における頭蓋底軟骨肉腫の治療方針

空閑　太亮、村上　大輔、小宗　徳孝、藤岡　寛、三月田　祐平、宮本　雄介、吉本　幸司

第35回日本頭蓋底外科学会  2023.7 

経鼻内視鏡アプローチによる眼窩内筋円錐内腫瘍への挑戦

空閑　太亮、村上　大輔、藤岡　寛、下川　能史、三月田　祐平、小宗　徳孝、　宮本　雄介、秦　暢宏、中溝　玲、吉本　幸司

第34回日本頭蓋底外科学会  2022.7 

眼窩内腫瘍に対する内視鏡手術の可能性

空閑　太亮、村上　大輔、藤岡　寛、下川　能史、三月田　祐平、小宗　徳孝、　宮本　雄介、秦　暢宏、中溝　玲、吉本　幸司

第81回日本日本脳神経外科学会学術総会.  2022.9 

経鼻内視鏡下手術におけるチーム医療の構築とその有益性

空閑　太亮、村上　大輔、藤岡　寛、下川　能史、三月田　祐平、小宗　徳孝、　宮本　雄介、秦　暢宏、中溝　玲、吉本　幸司

第35回 日本内視鏡外科学会総会  2022.12 

解剖から考える眼窩内腫瘍に対するアプローチ選択

空閑　太亮、村上　大輔、藤岡　寛、下川　能史、三月田　祐平、小宗　徳孝、　宮本　雄介、秦　暢宏、中溝　玲、吉本　幸司

第36回日本日本微小脳神経外科解剖研究会  2022.7 

当院での眼科内海綿状血管腫の治療経験空閑　太亮、村上　大輔、藤岡　寛、下川　能史、三月田　祐平、小宗　徳孝、　宮本　雄介、秦　暢宏、中溝　玲、吉本　幸司

空閑　太亮、村上　大輔、藤岡　寛、下川　能史、三月田　祐平、小宗　徳孝、　宮本　雄介、秦　暢宏、中溝　玲、吉本　幸司

第27回日本脳腫瘍の外科学会  2022.10 

経鼻内視鏡下手術におけるチーム医療の構築とその有益性

空閑　太亮、村上　大輔、藤岡　寛、下川　能史、三月田　祐平、小宗　徳孝、　宮本　雄介、秦　暢宏、中溝　玲、吉本　幸司

第29回日本神経内視鏡学会  2022.11 

NEI VFQ-25を用いたPitNET患者術前後のQOL評価

空閑　太亮、三月田　祐平、中溝　玲、吉本　幸司

第33回日本間脳下垂体腫瘍学会  2023.2 

経鼻内視鏡手術の適応拡大を目指して Invited

空閑　太亮

第29回日本神経内視鏡学会  2022.11 

眼窩内筋円錐内腫瘍に対する経鼻内視鏡手術

空閑　太亮、村上　大輔、小宗　徳孝、藤岡　寛、下川　能史、三月田　祐平、迎　伸孝、宮本　雄介、秦　暢宏、溝口　昌弘、吉本　幸司

第80回日本脳神経外科学会総会  2021.10 

頭蓋底病変に対するendoscopic multi-portal multi-corridor surgery

空閑　太亮、村上　大輔、小宗　徳孝、藤岡　寛、下川　能史、三月田　祐平、迎　伸孝、宮本　雄介、秦　暢宏、溝口　昌弘、吉本　幸司

2021.11 

頭蓋底外側病変に対するendoscopic multi-portal multi-corridor surgery

空閑　太亮、村上　大輔、小宗　徳孝、藤岡　寛、下川　能史、三月田　祐平、迎　伸孝、宮本　雄介、秦　暢宏、溝口　昌弘、吉本　幸司

第26回脳腫瘍の外科学会  2021.9 

頭蓋底外側病変に対する内視鏡手術の応用と工夫

空閑　太亮、村上　大輔、小宗　徳孝、迎　伸孝、宮本　雄介、秦　暢宏、溝口　昌弘、中川　尚志

第25回脳腫瘍の外科学会  2020.9 

長期経過からみた神経下垂体部germ cell tumorの診断／治療戦略

空閑 太亮

間脳下垂体学会  2017.2 

IDH mutant, 1p/19q codeletd Oligodendroglial tumorの長期予後

空閑 太亮

日本脳腫瘍学会  2016.12 

日本脳神経外科コングレス

liquid biopsyによる、神経膠腫の非侵襲的診断/病態把握システムの開発

2020 - 2023

日本学術振興会  科学研究費助成事業  基盤研究(C)

頭蓋内胚細胞腫瘍のバイオマーカー同定

2018.8

新規バイオマーカーに基づく頭蓋内胚細胞腫瘍の革新的診断／治療システムの開発

Grant number：18K08970  2018 - 2020

日本学術振興会  科学研究費助成事業  基盤研究(C)

膠芽腫に対するBevacizumab治療における血中バイオマーカーの同定

Grant number：16K20015  2016 - 2017

科学研究費助成事業  若手研究(B)

臨床医学論

2015.10 - 2016.3   Second semester